"According to the schedule, the committee will no longer consider the RSV vaccine, but it will vote on the three other shots described in this story: COVID-19, hepatitis B and MMRV. Next week, the panel of top advisers who recommend how vaccines are used in the United States will meet to review jabs that protect against COVID-19, hepatitis B and other diseases."
"I'm very concerned, given the signalling from the members of this newly reconstituted, hand-picked [committee] that they are going to select targets for further restriction, says Andrew Pavia, a physician with the Infectious Diseases Society of America, a medical association based in Arlington, Virginia. At their last meeting, the advisers several of whom have publicly expressed anti-vaccine views voted to end the use of the preservative thimerosal in influenza vaccines, despite evidence that it is safe at the doses found in jabs."
An upcoming ACIP meeting will review vaccines protecting against COVID-19, hepatitis B and other diseases. An updated draft agenda removes the RSV vaccine and indicates votes on COVID-19, hepatitis B and MMRV. The meeting is the committee's second since US health secretary Robert F. Kennedy Jr replaced the prior 17 members with seven new appointees. Public-health specialists express concern because several advisers have publicly expressed anti-vaccine views and because some vaccines on the agenda have long-established safety and efficacy. The agenda was posted with little detail and short notice, increasing researchers' concern about presentation plans and targets for restriction.
Read at www.nature.com
Unable to calculate read time
Collection
[
|
...
]